Skip to main content

Breathe BioMedical (BBM) CEO, Dr. Stephen Graham attended the Biotechnology Innovation Organization (BIO) International Convention in San Diego as part of the Atlantic Canada Delegation, alongside the Atlantic Canada BioIndustries Alliance. BIO 2022 was the first in person meeting in two years and Dr. Graham connected with industry, research and government leaders as well as representing BBM’s breath analytics technology on a global scale.  

BBM CEO, Dr. Stephen Graham seated in between Atlantic Premiers Andrew Furey (left) and Dennis King.

BIO is the largest biotechnology convention in the world. The convention brings together industry leaders from across the globe to share ideas and connect. There were over 100 interactive sessions, as well as courses, presentations and meetings held at this convention, allowing for unprecedented access to networking.  

“BIO 2022 was a fantastic convention filled with great networking and learning opportunities,” said Breathe BioMedical CEO, Stephen Graham. “It was a thrill to introduce our ground-breaking breath analytics technology to stakeholders from around the world. Many opportunities and potential partnerships have come out of this convention, and I look forward to working with these new collaborators to bring breath testing for disease into the mainstream of healthcare.” 

BBM CEO, Dr. Stephen Graham among government leaders and Atlantic Canada representatives at the ACTN announcement.

At the convention, Atlantic Canada government leaders – including Premiers and Health Ministers – announced the Atlantic Clinical Trials Network (ACTN). This network will foster innovation, produce world-class research, and most importantly, improve health treatments and outcomes for Atlantic Canadians.  

One of the major highlights in San Diego was getting the chance to network and share experiences with other Atlantic Canadian partners and companies. Dr. Graham had the opportunity to lead many formal presentations about our company before our local representatives in government, research and industry, including at the Atlantic Canada BioIndustries Roundtable. 

Breathe BioMedical is proud to represent New Brunswick and Atlantic Canada on a global stage and grateful for the opportunities BIO provides. Thank you to the convention organizers and attendees – we look forward to attending again next year! 

Breathe BioMedical welcomes the opportunity to grow our business network. If you are interested in partnering with Breathe BioMedical, email us at    


Leave a Reply

Breathe BioMedical Headquarters
191 Halifax Street
Moncton, NB E1C 9R6

T: 506-855-2400

Breathe BioMedical Inc.
245 Main, 2nd Floor
Cambridge, MA 02142

T: 617-203-2089